1. Nevue, Alexander A, Sairavi, Anusha, Huang, Samuel J, Nakai, Hiroyuki, Mello, Claudio V. 2024. Genomic loss of GPR108 disrupts AAV transduction in birds. In bioRxiv : the preprint server for biology, , . doi:10.1101/2024.05.16.589954. https://pubmed.ncbi.nlm.nih.gov/38798475/
2. Dudek, Amanda M, Zabaleta, Nerea, Zinn, Eric, Zhou, Guo Ling, Vandenberghe, Luk H. 2019. GPR108 Is a Highly Conserved AAV Entry Factor. In Molecular therapy : the journal of the American Society of Gene Therapy, 28, 367-381. doi:10.1016/j.ymthe.2019.11.005. https://pubmed.ncbi.nlm.nih.gov/31784416/
3. Dong, Danfeng, Zhou, Haisheng, Na, Soon-Young, Seed, Brian, Zhou, Guo Ling. 2018. GPR108, an NF-κB activator suppressed by TIRAP, negatively regulates TLR-triggered immune responses. In PloS one, 13, e0205303. doi:10.1371/journal.pone.0205303. https://pubmed.ncbi.nlm.nih.gov/30332431/
4. Meisen, W Hans, Nejad, Zahra Bahrami, Hardy, Miki, Ollmann, Michael M, Collins, Patrick J. 2020. Pooled Screens Identify GPR108 and TM9SF2 as Host Cell Factors Critical for AAV Transduction. In Molecular therapy. Methods & clinical development, 17, 601-611. doi:10.1016/j.omtm.2020.03.012. https://pubmed.ncbi.nlm.nih.gov/32280726/